Romania – Various medicinal products – Framework agreement - supply of OTC medicines
Framework agreement for the supply of OTC medicines - the quantities related to the framework agreement are detailed in section "II.2 List of lots". Subsequent contracts will generally be awarded semiannually; in certain situations, they may be concluded monthly/quar
Opportunity description
Framework agreement for the supply of OTC medicines - the quantities related to the framework agreement are detailed in section "II.2 List of lots". Subsequent contracts will generally be awarded semiannually; in certain situations, they may be concluded monthly/quarterly, depending on requirements and the budget allocation for this purpose. The minimum and maximum quantities related to a subsequent contract are specified in "II.2. List of lots". The number of days before the deadline for submission of tenders/applications by which clarifications may be requested is 16 days. The contracting authority establishes a single deadline by which it will respond clearly and completely to all requests for clarifications/additional information, on the 10th day before the deadline for submission of tenders. Any request for clarifications must be submitted in SEAP. Acetylcysteinum 200mg - caps - pharmaceutical form: caps; concentration: 200mg/caps; Min. qty. framework agreement - 21.000 caps; Max. qty. framework agreement - 84.456 caps; Estimated value of the framework agreement excluding VAT: between 23.100,00 and 92.901.60 RON Min. qty. subsequent contract - 7.000 caps; Max. qty. subsequent contract - 21.000 caps; Estimated value of the subsequent contract excluding VAT: between 7.700,00 and 23.100,00 RON Saccharomyces boulardii 250 mg - caps - pharmaceutical form: caps; concentration 250mg; Min. qty. framework agreement - 5.000 caps; Max. qty. framework agreement - 20.000 caps; Estimated value of the framework agreement excluding VAT: between 17.850,00 and 71.400,00 RON Min. qty. subsequent contract - 1.600 caps; Max. qty. subsequent contract - 5.000 caps; Estimated value of the subsequent contract excluding VAT: between 5.712,00 and 17.850,00 RON Silibinum 150mg - cpr/caps/dj - pharmaceutical form: cpr/caps/draj; concentration: 150mg cpr/caps/dj; Min. qty. framework agreement - 6.000 cpr/caps/dj; Max. qty. framework agreement - 24.000 cpr/caps/dj; Estimated value of the framework agreement excluding VAT: between 8.340,00 and 33.360,00 RON Min. qty. subsequent contract - 2.000 cpr/caps/dj; Max. qty. subsequent contract - 6.000 cpr/caps/dj; Estimated value of the subsequent contract excluding VAT: between 2.780,00 and 8.340,00 RON Procedure: open. Estimated value: 197,661.6 RON. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.